Pelvic Reconstruction Market Applications, Outlook, SWOT Analysis And Forecast By 2032 | FMI

 The global Pelvic Reconstruction Market is anticipated to reach a value of US$ 277.8 Million by the end of 2022 and continue to grow at a CAGR of 2.8% to reach US$ 366.9 Million by 2032. Vaginal slings systems held the market's top spot in terms of the product category in 2021 with a share of almost 54.2%.

To learn more about this report: https://www.futuremarketinsights.com/reports/pelvic-reconstruction-market

Furthermore, increasing awareness regarding vaginal health due to growing cases of pelvic disorders and deformities have surged the need for pelvic reconstruction products. On the back of this, key players are vying to develop systems that can be approved by regulatory authorities such as the FDA.


Additionally, growing acceptance of pelvic floor reconstruction procedures in hospitals and specialty clinics is prompting the adoption of advanced systems for accurate and speedy recovery. There is also an increase in the research and development on ways to handle pelvic floor disorders by mitigating the risk factors.

Increasing use of tissue engineering to support pelvic floor and also promotes tissue repair. This is also highly biocompatible compared to the general approach of using polypropylene mesh. Hence, several ongoing research is focusing on tissue engineering such as the use of fibroblasts and stem cells is supporting the growth in pelvic reconstruction market.

Key Takeaways from Market Study

  • Based on product type, vaginal sling systems held approximately 54.2% market value share in 2021, owing to rising cases of pelvic floor disorders.
  • Surgical procedure is set to lead the market, in terms of procedures, and contributed around 78.9% of revenue in 2021.
  • By indication, pelvic organ prolapse is expected to register growth at a CAGR of 2.7% during the forecast period.
  • By pelvic organs, the vagina is the most affected organ and the segment held a share of about 38.6% in 2021.
  • North America is considered as the leading region with a value share of 33.9% in 2021, owing to the high prevalence of pelvic floor disorders in the region.

“Rising initiatives to promote safety and mitigate risk, as well as the increasing research and development for the improvement of treatment approaches is set to propel the sales of pelvic reconstruction products across the globe,” says an analyst of Future Market Insights.

Pelvic Floor Reconstruction is a surgical procedure that involves rebuilding or restoring the structure and function of the pelvis, which is the bony structure that connects the spine to the legs. Pelvic reconstruction may be required following trauma or injury to the pelvis, such as fractures or dislocations, or as a result of conditions that affect the pelvic bones, such as tumors or infections.

Market Competition

The market for pelvic reconstruction consists of a number of local as well as established players within the market sphere. There is increased research and development to meet the current needs of the population.

  • In 2019, as per research conducted by Royal Hallamshire Hospital, UK, Ulrich et al. demonstrated that endometrial MSCs seeded onto gelatin-coated polyamide mesh had an anti-inflammatory effect and promoted neovascularization in a rat model.
  • Onkos Surgical declared in July 2022 that its My3D® Personalized Pelvic Reconstruction system had been granted 510(k) approval.

Key Companies Profiled in the Study are –

  • Johnson & Johnson Services, Inc.
  • Coloplast A/S
  • Dipromed Srl
  • Boston Scientific Corporation (American Medical Systems Inc.)
  • pfm medical ag
  • Betatech Medical
  • Others

Key Market Segments Covered In Pelvic Reconstruction Industry Research

By Product:

  • Vaginal Mesh
    • Biological Mesh
    • Synthetic Mesh
  • Vaginal Sling Systems
  • Vaginal Pessary

By Procedure:

  • Non-Surgical
  • Surgical
    • Obliterative surgery
    • Reconstructive surgery
  • Native Tissue Repair (uterosacral ligament suspension and sacrospinous fixation)
  • Colporrhalphy
  • Sacrocolpopexy
  • Sacrohysteropexy
  • Transvaginal graft
  • Sling Surgery

By Indication:

  • Pelvic Organ Prolapse
  • Vaginal Prolapse
  • Rectal Prolapse
  • Urinary Incontinence
  • Interstitial Cystitis
  • Fistulae

By Pelvic Organs:

  • Uterus
  • Ovaries
  • Vagina
  • Fallopian Tubes

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Primary Sclerosing Cholangitis (PSC) Market Size, Opportunities and Forecast 2023-2033

Image
  The global Primary Sclerosing Cholangitis (PSC) Market is anticipated to be worth US$ 151.07 million in 2023.  Primary Sclerosing Cholangitis (PSC) With growing alcohol consumption, the worldwide market for Primary Sclerosing Cholangitis (PSC) is expected to develop at a CAGR of 7.6% between 2023 and 2033, totaling roughly US$ 314.26 Million by 2033. According to the analysis of Future Market Insights, the Primary Sclerosing Cholangitis (PSC) market is expected to fuel over the analysis period, attributed to the factors such as the rise in the incidences of liver diseases, as well as rise in alcohol consumption. Get Full Access @ https://www.futuremarketinsights.com/reports/primary-sclerosing-cholangitis-psc-market  As per the Centers for Disease Control and Prevention, the global incidence of liver disease was 3.9 million in 2016. As per the World Health Organization (WHO), prevalence of liver cirrhosis is increasing in the European countries, due to high con...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more